Cardio-renal protective effect and safety of sodium-glucose cotransporter 2 inhibitors for chronic kidney disease patients with eGFR < 60 mL/min/1.73 m2: a systematic review and meta-analysis

Yaru Zhang(Second People Hospital of Hunan), Nanlan Chen(Jiangxi Pingxiang People's Hospital), Junhui Luo(Second People Hospital of Hunan), Bingxin Li(Hebei Medical University), Junying Xu(Wuxi People's Hospital), Hong Yu(Shanghai Jiao Tong University)
BMC Nephrology
November 1, 2024
Cited by 11


Related Papers